Trial Profile
Multi-center, open-labed, prospective study of cilostazol (Pletaal) Effect on uncontrolled Variant angina
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Cilostazol (Primary)
- Indications Embolism and thrombosis; Variant angina pectoris
- Focus Therapeutic Use
- Acronyms PEVA
- 13 Sep 2011 New trial record